The Blog
-
Mar 06, 2025
AOD-9604: The Fat-Burning Peptide Explained
READ MORE -
Mar 06, 2025
Targeting PGD2 Signaling: A Promising Approach for Treating Eosinophilic Diseases and Beyond
READ MORE -
Mar 05, 2025
Resmetirom: A Breakthrough Treatment for MASH and the Future of Liver Disease Management
READ MORE -
Mar 04, 2025
Laduviglusib: A GSK3β Inhibitor with Potential Across Multiple Diseases
READ MORE -
Feb 28, 2025
The Role of EGF (Epidermal Growth Factor) in the Construction of Organoid Models
READ MORE -
Feb 28, 2025
Hexamethyldisiloxane (HMDSO): A Versatile Compound in Electronics, Coatings, and Beyond
READ MORE -
Feb 27, 2025
Economic Considerations and Future Outlook for Resmetirom in the Treatment of MASH
READ MORE -
Feb 21, 2025
Cariprazine in Major Depressive Disorder: A Promising Adjunctive Treatment for Treatment-Resistant Depression
READ MORE -
Feb 20, 2025
Is the Drug Activity Designed by AI Reliable?
READ MORE